CDHR2

gene
On this page

Also known as PC-LKCFLJ20124FLJ20383PCLKC

Summary

CDHR2 (cadherin related family member 2, HGNC:18231) is a protein-coding gene on chromosome 5q35.2, encoding Cadherin-related family member 2 (Q9BYE9). Intermicrovillar adhesion molecule that forms, via its extracellular domain, calcium-dependent heterophilic complexes with CDHR5 on adjacent microvilli.

This gene is a member of the protocadherin family, which represents a subset of the larger cadherin superfamily. The members of the protocadherin family encode non-classical cadherins that function as calcium-dependent cell-cell adhesion molecules. This protocadherin represents a new candidate for tumor suppression. Alternatively spliced transcript variants that encode the same protein have been identified.

Source: NCBI Gene 54825 — RefSeq curated summary.

At a glance

  • GWAS associations: 1
  • Clinical variants (ClinVar): 281 total — 2 pathogenic
  • MANE Select transcript: NM_017675

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:18231
Approved symbolCDHR2
Namecadherin related family member 2
Location5q35.2
Locus typegene with protein product
StatusApproved
AliasesPC-LKC, FLJ20124, FLJ20383, PCLKC
Ensembl geneENSG00000074276
Ensembl biotypeprotein_coding
OMIM619713
Entrez54825

Gene structure

Transcript identifiers

Ensembl transcripts: 18 — 13 protein_coding, 4 retained_intron, 1 nonsense_mediated_decay

ENST00000261944, ENST00000416365, ENST00000506348, ENST00000508085, ENST00000510124, ENST00000510636, ENST00000513031, ENST00000888592, ENST00000888593, ENST00000888594, ENST00000888595, ENST00000888596, ENST00000888597, ENST00000888598, ENST00000888599, ENST00000888600, ENST00000888601, ENST00000955721

RefSeq mRNA: 2 — MANE Select: NM_017675 NM_001171976, NM_017675

CCDS: CCDS34297

Canonical transcript exons

ENST00000261944 — 32 exons

ExonStartEnd
ENSE00000973824176565672176565743
ENSE00000973825176568678176568817
ENSE00000973826176568960176569010
ENSE00000973827176571213176571302
ENSE00000973828176574083176574172
ENSE00000973840176584190176584259
ENSE00000973841176584410176585015
ENSE00000973842176585954176586025
ENSE00000973843176586793176586842
ENSE00001055406176575724176575839
ENSE00001055412176590563176590687
ENSE00001055414176575280176575426
ENSE00001055415176575084176575209
ENSE00001055420176577399176577554
ENSE00001055423176581343176581582
ENSE00001055427176575506176575581
ENSE00001129085176565338176565404
ENSE00001159367176578365176578608
ENSE00001159418176577637176577798
ENSE00001196538176591404176591484
ENSE00001196573176578034176578095
ENSE00001431143176549342176549414
ENSE00001507332176595532176595824
ENSE00001507333176592723176592780
ENSE00001507334176575952176576185
ENSE00003470241176590078176590146
ENSE00003509115176590425176590485
ENSE00003527350176589330176589438
ENSE00003528588176591210176591323
ENSE00003547257176589031176589182
ENSE00003601680176589528176589616
ENSE00003649482176590253176590330

Expression profiles

Bgee: expression breadth ubiquitous, 176 present calls, max score 98.99.

FANTOM5 (CAGE): breadth tissue_specific, TPM avg 1.5806 / max 1012.3984, expressed in 47 samples.

FANTOM5 promoters (5 alternative TSS)

Promoter IDTPM avgSamples expressed
604201.414941
604190.110727
604250.04593
604230.00623
604240.00292

Top tissues by expression

276 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
jejunal mucosaUBERON:000039998.99gold quality
ileal mucosaUBERON:000033197.16gold quality
duodenumUBERON:000211496.99gold quality
mucosa of transverse colonUBERON:000499192.87gold quality
small intestine Peyer’s patchUBERON:000345491.49gold quality
small intestineUBERON:000210891.04gold quality
cortical plateUBERON:000534389.43gold quality
rectumUBERON:000105288.84gold quality
left testisUBERON:000453388.00gold quality
right lobe of liverUBERON:000111487.48gold quality
spermCL:000001986.73gold quality
jejunumUBERON:000211586.39gold quality
colonic mucosaUBERON:000031786.38gold quality
liverUBERON:000210786.31gold quality
right testisUBERON:000453486.27gold quality
transverse colonUBERON:000115785.38gold quality
mucosa of sigmoid colonUBERON:000499384.64gold quality
male germ cellCL:000001584.44gold quality
testisUBERON:000047384.29gold quality
right frontal lobeUBERON:000281083.40gold quality
anterior cingulate cortexUBERON:000983583.35gold quality
cingulate cortexUBERON:000302783.21gold quality
ganglionic eminenceUBERON:000402382.17gold quality
amygdalaUBERON:000187681.71gold quality
pancreatic ductal cellCL:000207981.68silver quality
adult mammalian kidneyUBERON:000008281.62gold quality
right hemisphere of cerebellumUBERON:001489081.60gold quality
islet of LangerhansUBERON:000000681.28gold quality
cerebellar hemisphereUBERON:000224580.78gold quality
cerebellar cortexUBERON:000212980.54gold quality

Single-cell (SCXA)

Detected in 2 experiment(s), a significant marker in 2.

ExperimentMarker?Max mean expression
E-GEOD-125970yes67.64
E-ANND-3yes11.23

Regulation

Is transcription factor: no

Literature-anchored findings (GeneRIF, showing 4)

  • suppression of beta-catenin signaling by PCDH24 leads to contact inhibition (PMID:19383367)
  • CDHR24 is directly involved in cell and tissue morphogenesis (PMID:22628312)
  • Study found that brush border assembly is driven by the formation of Ca(2+)-dependent adhesion links between adjacent microvilli. Intermicrovillar links are composed of protocadherin-24 and mucin-like protocadherin, which target to microvillar tips and interact to form a trans-heterophilic complex. (PMID:24725409)
  • Heterophilic and homophilic cadherin interactions in intestinal intermicrovillar links are species dependent. (PMID:34871294)

Cross-species orthologs

2 orthologs

OrganismSymbolGene ID
mus_musculusCdhr2ENSMUSG00000034918
rattus_norvegicusCdhr2ENSRNOG00000017917

Paralogs (33): CDH1 (ENSG00000039068), CDH10 (ENSG00000040731), CDH3 (ENSG00000062038), CDH19 (ENSG00000071991), CDH17 (ENSG00000079112), CDH7 (ENSG00000081138), PCDH11Y (ENSG00000099715), CDHR5 (ENSG00000099834), CDH20 (ENSG00000101542), PCDH11X (ENSG00000102290), CDH23 (ENSG00000107736), CDH9 (ENSG00000113100), CDH6 (ENSG00000113361), CDH26 (ENSG00000124215), CDHR3 (ENSG00000128536), CDH15 (ENSG00000129910), CDH24 (ENSG00000139880), CDH11 (ENSG00000140937), CDH13 (ENSG00000140945), CDH18 (ENSG00000145526), CDHR1 (ENSG00000148600), CDH22 (ENSG00000149654), CDH8 (ENSG00000150394), CDH12 (ENSG00000154162), PCDH1 (ENSG00000156453), DCHS1 (ENSG00000166341), PCDH7 (ENSG00000169851), CDH2 (ENSG00000170558), CDH4 (ENSG00000179242), CDH5 (ENSG00000179776), PCDH9 (ENSG00000184226), DCHS2 (ENSG00000197410), PCDH20 (ENSG00000280165)

Protein

Protein identifiers

Cadherin-related family member 2Q9BYE9 (reviewed: Q9BYE9)

Alternative names: Protocadherin LKC, Protocadherin-24

All UniProt accessions (2): Q9BYE9, D6REJ3

UniProt curated annotations — full annotation on UniProt →

Function. Intermicrovillar adhesion molecule that forms, via its extracellular domain, calcium-dependent heterophilic complexes with CDHR5 on adjacent microvilli. Thereby, controls the packing of microvilli at the apical membrane of epithelial cells. Through its cytoplasmic domain, interacts with microvillus cytoplasmic proteins to form the intermicrovillar adhesion complex/IMAC. This complex plays a central role in microvilli and epithelial brush border differentiation. May also play a role in cell-cell adhesion and contact inhibition in epithelial cells.

Subunit / interactions. Part of the IMAC/intermicrovillar adhesion complex/intermicrovillar tip-link complex composed of ANKS4B, MYO7B, USH1C, CDHR2 and CDHR5. Interacts with MAST2. Interacts (via cytoplasmic domain) with USH1C and MYO7B; required for proper localization of CDHR2 to microvilli tips and its function in brush border differentiation.

Subcellular location. Apical cell membrane. Cell projection. Microvillus membrane. Cell junction.

Tissue specificity. Highly expressed in liver, kidney and colon. Moderately expressed in small intestine. Down-regulated in a number of liver and colon cancers. Expressed in duodenum with higher expression in enterocytes along the villus axis and lower expression in crypts (at protein level).

Domain organisation. The cadherin 1 domain is required for binding to CDHR5.

RefSeq proteins (2): NP_001165447, NP_060145* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR002126Cadherin-like_domDomain
IPR015919Cadherin-like_sfHomologous_superfamily
IPR020894Cadherin_CSConserved_site

Pfam: PF00028

UniProt features (81 total): glycosylation site 24, strand 18, domain 9, sequence variant 9, helix 4, turn 3, region of interest 2, compositionally biased region 2, modified residue 2, topological domain 2, sequence conflict 2, signal peptide 1, chain 1, transmembrane region 1, mutagenesis site 1

Structure

Experimental structures (PDB)

2 structures.

PDBMethodResolution (Å)
5CZRX-RAY DIFFRACTION2.3
7N86X-RAY DIFFRACTION3.17

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q9BYE9-F180.840.31

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Post-translational modifications (2): 1248, 1299

Glycosylation sites (24): 29, 134, 182, 188, 195, 300, 355, 371, 401, 460, 565, 600, 616, 632, 680, 696, 701, 775, 821, 871 …

Mutagenesis-validated functional residues (1):

PositionPhenotype
1310loss of interaction with ush1c.

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 93 (showing top): GOBP_EPITHELIUM_DEVELOPMENT, GOBP_NEGATIVE_REGULATION_OF_CELL_GROWTH, GOBP_GROWTH, GOBP_NEUROGENESIS, GOBP_CELL_CELL_ADHESION, GOBP_REGULATION_OF_ANATOMICAL_STRUCTURE_SIZE, GOBP_REGULATION_OF_CELL_PROJECTION_ORGANIZATION, MODULE_205, ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_DN, GOCC_APICAL_PLASMA_MEMBRANE, GOBP_DETECTION_OF_STIMULUS, GOBP_REGULATION_OF_MICROVILLUS_ORGANIZATION, GOBP_HOMOTYPIC_CELL_CELL_ADHESION, GOBP_CELL_PROJECTION_ORGANIZATION, BREDEMEYER_RAG_SIGNALING_NOT_VIA_ATM_UP

GO Biological Process (12): homophilic cell-cell adhesion (GO:0007156), axonogenesis (GO:0007409), epithelial cell differentiation (GO:0030855), regulation of microvillus length (GO:0032532), cell-cell adhesion mediated by cadherin (GO:0044331), negative regulation of cell growth involved in contact inhibition (GO:0060243), intermicrovillar adhesion (GO:0090675), brush border assembly (GO:1904970), cell adhesion (GO:0007155), cell differentiation (GO:0030154), epithelium development (GO:0060429), cell-cell adhesion (GO:0098609)

GO Molecular Function (3): calcium ion binding (GO:0005509), cell adhesion molecule binding (GO:0050839), protein binding (GO:0005515)

GO Cellular Component (11): plasma membrane (GO:0005886), microvillus (GO:0005902), brush border (GO:0005903), adherens junction (GO:0005912), apical plasma membrane (GO:0016324), brush border membrane (GO:0031526), microvillus membrane (GO:0031528), extracellular exosome (GO:0070062), membrane (GO:0016020), cell projection (GO:0042995), anchoring junction (GO:0070161)

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
cell-cell adhesion2
microvillus2
apical part of cell2
cell projection membrane2
cellular anatomical structure2
cell morphogenesis involved in neuron differentiation1
neuron projection morphogenesis1
axon development1
cell differentiation1
epithelium development1
regulation of microvillus organization1
regulation of cell projection size1
negative regulation of cell growth1
contact inhibition1
homotypic cell-cell adhesion1
brush border assembly1
cellular component assembly1
cellular process1
cellular developmental process1
tissue development1
cell adhesion1
metal ion binding1
protein binding1
binding1
membrane1
cell periphery1
actin filament bundle1
actin-based cell projection1
cluster of actin-based cell projections1
cell-cell junction1
plasma membrane region1
brush border1
apical plasma membrane1
extracellular vesicle1
cell junction1

Protein interactions and networks

STRING

894 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
CDHR2CDHR5Q9HBB8991
CDHR2E9PNW1E9PNW1828
CDHR2ANKS4BQ8N8V4790
CDHR2MYO7BQ6PIF6790
CDHR2GPRIN1Q7Z2K8566
CDHR2KNDC1Q76NI1518
CDHR2ADGRA1Q86SQ6476
CDHR2ESPNB1AK53463
CDHR2IGDCC4Q8TDY8433
CDHR2CDHR4A6H8M9432
CDHR2PCDH15Q96QU1420
CDHR2ACRV1P26436417
CDHR2OR8A1Q8NGG7410
CDHR2RAB24Q969Q5398
CDHR2TMEM164Q5U3C3391

IntAct

22 interactions, top by confidence:

ABTypeScore
CDHR2CDHR5psi-mi:“MI:0407”(direct interaction)0.590
CDHR5CDHR2psi-mi:“MI:0407”(direct interaction)0.590
CDHR5CDHR2psi-mi:“MI:0915”(physical association)0.590
CDHR2CDHR5psi-mi:“MI:0915”(physical association)0.590
CDHR2MAST2psi-mi:“MI:0915”(physical association)0.540
MAST2CDHR2psi-mi:“MI:0915”(physical association)0.540
MAST2CDHR2psi-mi:“MI:0403”(colocalization)0.540
CDHR2USH1Cpsi-mi:“MI:0915”(physical association)0.520
USH1CCDHR2psi-mi:“MI:0915”(physical association)0.520
CDHR2MYO7Bpsi-mi:“MI:0915”(physical association)0.460
CDHR2MYO7Bpsi-mi:“MI:0403”(colocalization)0.460
GNAT3psi-mi:“MI:0915”(physical association)0.400
RPS6KA2IPO7psi-mi:“MI:0914”(association)0.350
RPS6KA6HMGN1psi-mi:“MI:0914”(association)0.350
CDHR2HIP1Rpsi-mi:“MI:0914”(association)0.350
CDHR2CDHR5psi-mi:“MI:0403”(colocalization)0.270
CDHR2USH1Cpsi-mi:“MI:0403”(colocalization)0.270

BioGRID (15): MAST2 (Affinity Capture-Western), MAST2 (Co-localization), NF1 (Affinity Capture-MS), HIP1R (Affinity Capture-MS), MAST2 (Two-hybrid), MRS2 (Affinity Capture-MS), LAMB1 (Affinity Capture-MS), TMTC2 (Affinity Capture-MS), SURF1 (Affinity Capture-MS), FBXO2 (Affinity Capture-MS), TBCD (Affinity Capture-MS), LGALS1 (Affinity Capture-MS), CDHR2 (Affinity Capture-MS), CDHR2 (Affinity Capture-MS), NUP88 (Cross-Linking-MS (XL-MS))

ESM2 similar proteins: E9Q7P9, O88277, O93319, P55280, P55281, P55285, P55289, P70408, P79995, P97326, Q08DJ5, Q12864, Q13634, Q14517, Q24298, Q2PZL6, Q3SWX5, Q5DWV1, Q5DWV2, Q5F226, Q63315, Q6B3P0, Q6KEQ9, Q6V0I7, Q6WXV7, Q6WYY1, Q6X862, Q6ZTQ4, Q71M42, Q8BIZ0, Q8BL00, Q8BM92, Q8BNA6, Q8N6Y1, Q8QGH3, Q8R508, Q8TDW7, Q90762, Q90763, Q91838

Diamond homologs: B2KI42, E9Q7P9, O18926, O54800, O55075, O93319, P08641, P20310, P30944, P33147, P55280, P55284, P55286, P55287, P55288, P58365, P97291, P97326, Q2PZL6, Q3SWX5, Q63418, Q6B457, Q6PB90, Q6PFX6, Q767I8, Q86UP0, Q8AYD0, Q8UVJ7, Q8VHP6, Q8WN91, Q90762, Q90Z37, Q91XU7, Q91XZ4, Q96JP9, Q99PF4, Q9BYE9, Q9H251, Q9QYP2, D4ACX8

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

281 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic2
Likely pathogenic0
Uncertain significance228
Likely benign26
Benign0

Top pathogenic / likely-pathogenic (2)

Variant IDHGVSClassification
1707460Single allelePathogenic
2579264GRCh38/hg38 5q35.2-35.3(chr5:176447531-177312407)x1Pathogenic

SpliceAI

5205 predictions. Top by Δscore:

VariantEffectΔscore
5:176542770:G:GGdonor_gain1.0000
5:176568813:ACGAG:Adonor_loss1.0000
5:176568814:CGAGG:Cdonor_loss1.0000
5:176568815:GAGGT:Gdonor_loss1.0000
5:176568816:AGG:Adonor_loss1.0000
5:176568817:GGTA:Gdonor_loss1.0000
5:176568818:G:GAdonor_loss1.0000
5:176568819:T:Gdonor_loss1.0000
5:176568948:T:TAacceptor_gain1.0000
5:176571298:ACGAG:Adonor_loss1.0000
5:176571300:GAGGT:Gdonor_loss1.0000
5:176571301:AGGTG:Adonor_loss1.0000
5:176571302:GGTG:Gdonor_loss1.0000
5:176571303:G:Adonor_loss1.0000
5:176571322:G:GAdonor_gain1.0000
5:176574080:CAGAC:Cacceptor_loss1.0000
5:176574081:A:Cacceptor_loss1.0000
5:176574082:GACC:Gacceptor_gain1.0000
5:176574169:GAAG:Gdonor_gain1.0000
5:176574171:AGG:Adonor_loss1.0000
5:176574173:G:GCdonor_loss1.0000
5:176574174:T:Adonor_loss1.0000
5:176575082:A:AGacceptor_gain1.0000
5:176575083:G:GGacceptor_gain1.0000
5:176575083:GGTC:Gacceptor_gain1.0000
5:176575210:G:GGdonor_gain1.0000
5:176575387:G:GTdonor_gain1.0000
5:176575415:G:GTdonor_gain1.0000
5:176575422:CCAAG:Cdonor_loss1.0000
5:176575423:CAAG:Cdonor_loss1.0000

AlphaMissense

8585 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
5:176577451:T:CF416S0.993
5:176576049:T:CF353S0.992
5:176577644:C:AA453D0.991
5:176584190:G:CD687H0.991
5:176576043:C:AP351H0.990
5:176578376:T:CF529S0.990
5:176578505:T:CL572P0.990
5:176589380:T:AV1020D0.990
5:176589568:T:GF1053C0.990
5:176576048:T:CF353L0.989
5:176576050:T:AF353L0.989
5:176576050:T:GF353L0.989
5:176577450:T:CF416L0.989
5:176577452:C:AF416L0.989
5:176577452:C:GF416L0.989
5:176589567:T:CF1053L0.989
5:176589569:C:AF1053L0.989
5:176589569:C:GF1053L0.989
5:176571262:C:AP122H0.988
5:176571268:T:GF124C0.988
5:176574131:G:CD152H0.988
5:176575953:C:AA321D0.988
5:176577719:C:AP478H0.988
5:176578468:G:CA560P0.988
5:176584439:G:CD720H0.988
5:176584476:T:CF732S0.988
5:176589367:T:GY1016D0.988
5:176584440:A:CD720A0.987
5:176589568:T:CF1053S0.987
5:176574132:A:CD152A0.986

dbSNP variants (sampled 300 via entrez): RS1000015036 (5:176588750 G>T), RS1000078586 (5:176552825 C>T), RS1000216487 (5:176575084 G>A), RS1000218139 (5:176574451 A>C), RS1000231844 (5:176548112 C>G,T), RS1000302468 (5:176557914 G>T), RS1000334272 (5:176563413 C>A), RS1000428310 (5:176591108 C>T), RS1000446015 (5:176569086 C>A,T), RS1000539911 (5:176549436 G>A), RS1000577895 (5:176563717 C>T), RS1000586514 (5:176596461 A>G), RS1000724603 (5:176579759 C>T), RS1000732135 (5:176580446 T>C), RS1000786103 (5:176595383 G>A)

Disease associations

OMIM: gene MIM:619713 | disease phenotypes: MIM:117550

GenCC curated gene-disease

Mondo (2): 5q35 microduplication syndrome (MONDO:0016461), Sotos syndrome (MONDO:0019349)

Orphanet (2): 5q35 microduplication syndrome (Orphanet:228415), Sotos syndrome (Orphanet:821)

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

1 associations (top):

StudyTraitp-value
GCST008163_438Height3.000000e-06

MeSH disease descriptors (1)

DescriptorNameTree numbers
D058495Sotos SyndromeC16.131.077.889; C16.131.260.905; C16.320.180.905

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

13 total (human), top 13 by PubMed support.

ChemicalActions (top 5)PubMed papers
Cyclosporinedecreases expression, increases expression3
Benzo(a)pyrenedecreases expression, decreases methylation, affects methylation2
triphenyl phosphateaffects expression1
beta-lapachoneincreases expression1
tris(1,3-dichloro-2-propyl)phosphateincreases expression1
benzo(e)pyreneincreases methylation1
abrineincreases expression1
Resveratrolaffects cotreatment, decreases expression1
Methapyrileneincreases methylation1
Niclosamidedecreases expression1
Plant Extractsaffects cotreatment, decreases expression1
Aflatoxin B1decreases expression1
Okadaic Acidincreases expression1

Clinical trials (associated diseases)

1 trials via MONDO — disease-level, not drug-specific.

TrialPhaseStatusTitle
NCT04993235Not specifiedUNKNOWNBody Perception and Representation in Overgrowth Syndromes, Behavioral Assessment and Neuropsychological Development